Synvolux
Desconocido
EpiPredict: Epigenetic regulation of endocrine therapy resistance in breast cancer A systems medicine approach...
Synvolux Therapeutics BV
participó en un
H2020:
H2020-MSCA-ITN-2014
The mission of EpiPredict is to train a multidisciplinary cohort of young researchers in a new approach to fully exploit the epigenetics of...
2014-12-10 - 2018-12-31 | Financiado
2014-12-10 - 2018-12-31 | Financiado
* No se disponen de datos de la empresa actual.